The NSD3::NUTM1 fusion is reported exclusively in NUT carcinoma, an aggressive cancer typically characterized by epithelial differentiation and considered a subtype of squamous cell carcinoma [6,7]. This evidence concerns the gene NUTM1 and cancer.